Lothar Müller

Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial

Ralf‐Dieter Hofheinz, Frederik Wenz, Stefan Post et al. · The Lancet Oncology · 2012 · 501 citations

Radiation Therapy, Gastrointestinal Oncology, Medicine +8

Efficacy of Prophylactic Low–Molecular Weight Heparin for Ambulatory Patients With Advanced Pancreatic Cancer: Outcomes From the CONKO-004 Trial

Uwe Pelzer, Bernhard Opitz, G. Deutschinoff et al. · Journal of Clinical Oncology · 2015 · 262 citations

Recurrent finding of the FIP1L1-PDGFRA fusion gene in eosinophilia-associated acute myeloid leukemia and lymphoblastic T-cell lymphoma

Georgia Metzgeroth, Christoph Walz, J Score et al. · Leukemia · 2007 · 172 citations

Hematological Malignancy, Lymphoid Neoplasia, Fip1l1-pdgfra Fusion Gene +10

Irinotecan combined with infusional 5-fluorouracil/folinic acid or capecitabine plus celecoxib or placebo in the first-line treatment of patients with metastatic colorectal cancer. EORTC study 40015

C.-H. Köhne, Jacques De Grève, J. T. Hartmann et al. · Annals of Oncology · 2007 · 161 citations

Gastrointestinal Oncology, Medicine, Infusional 5-Fluorouracil/folinic Acid +8

The CLL12 trial: ibrutinib vs placebo in treatment-naïve, early-stage chronic lymphocytic leukemia

Petra Langerbeins, Can Zhang, Sandra Robrecht et al. · Blood · 2021 · 87 citations · Full text